Illumina Inc. (Nasdaq: ILMN) said it will sell Grail Inc. after a U.S. appeals court found that its $7 billion acquisition of the cancer detection startup violated antitrust laws.
To read the entire story, you must be logged in.
Please log in now or register with us.
